ICS OPPORTUNITIES II LLC 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-12 4:21 pm Purchase | 2024-09-09 | 13G | Aligos Therapeutics, Inc. ALGS | ICS OPPORTUNITIES II LLC | 125,451 4.100% | 125,451 (New Position) | Filing |